HEXIM Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of HEXIM Antibodies for advanced research in molecular biology. HEXIM Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HEXIM proteins regulate transcription by inhibiting positive transcription elongation factor b (P-TEFb) activity, which controls RNA polymerase II transition from transcription initiation to elongation. This regulation impacts various cellular processes, including cell cycle control and stress response, making HEXIM proteins significant in cancer and disease research. HEXIM monoclonal antibodies enable detailed investigation of transcription regulation mechanisms in both normal and pathological conditions. Researchers can effectively track HEXIM protein expression patterns and interactions across different cellular environments. Understanding HEXIM protein function contributes to developing targeted therapeutic approaches for various diseases. HEXIM monoclonal antibodies from Santa Cruz Biotechnology support researchers worldwide in advancing scientific understanding of transcriptional regulation and its impact on human health.